文献速递乳腺MR

BRCA突变携带者的MRI筛查:标准方案与含及不含T2加权图像的简化方案的比较

MRI Screening of BRCA Mutation Carriers: Comparison of Standard Protocol and Abbreviated Protocols With and Without T2-Weighted Images.
PubMed 文献 · AJR Am J Roentgenol · 2021-12-22

该回顾性研究纳入292例BRCA1或BRCA2突变携带者的427次筛查乳腺MRI,比较标准全方案与两种理论简化方案(含或不含T2加权序列)的诊断性能。结果显示不含T2的简化方案性能欠佳,而加入T2序列后敏感度和准确性与全方案相当,特异度较全方案轻度升高。

要点

  • 简化方案不含T2时特异度71%、准确率73%,均低于标准方案。
  • 简化方案加T2后敏感度90%、准确率83%,与标准方案相当。
  • 简化方案加T2后特异度83%,较标准方案80%轻度升高。

核心结论

  • 不含T2加权成像的简化方案性能欠佳,而加入T2序列后敏感度和准确性与全方案相当,特异度较全方案轻度升高。

研究设计与样本

  • 回顾性研究纳入292例BRCA1或BRCA2突变携带者(平均年龄47.9岁)的427次筛查乳腺MRI,按组织病理学或影像随访分为良性407次和恶性20次,由4名读者独立评估三种方案并赋予BI-RADS分类。

诊断标准与关键数值

  • 以BI-RADS 3-5类为阳性检查;合并敏感度标准方案94%、简化方案92%、简化加T2方案90%(均P>.001);合并特异度标准方案80%、简化方案71%、简化加T2方案83%(简化加T2与标准及简化方案比较P<.001);合并阳性预测值标准方案19%、简化方案14%、简化加T2方案20%(简化与标准及简化加T2比较P<.001);合并阴性预测值标准方案100%、简化方案99%、简化加T2方案99%(均P>.001);合并准确率标准方案80%、简化方案73%、简化加T2方案83%(简化与标准及简化加T2比较P<.001)。

临床应用与阅片要点

  • 作者认为研究结果支持在BRCA突变患者的乳腺癌筛查中实施含T2加权成像的简化MRI方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Increasing evidence supports the role of abbreviated MRI protocols for breast cancer detection. However, abbreviated protocols have been poorly studied in patients who are BRCA1 or BRCA2 mutation carriers. Furthermore, the need for T2-weighted sequences in abbreviated protocols remains controversial. OBJECTIVE. The purpose of this study was to compare, in the evaluation of patients with BRCA mutations, the diagnostic performance of a standard full breast MRI protocol with the performance of abbreviated protocols that included and did not include a T2-weighted sequence. METHODS. This retrospective study included 292 patients (mean age, 47.9 years) who were BRCA1 or BRCA2 mutation carriers who underwent 427 screening breast MRI examinations according to a standard full protocol who could be classified as having benign (n = 407) or malignant (n = 20) findings based on histopathology or imaging follow-up. Four readers independently assessed examinations in three separate sessions (theoretic abbreviated protocol, which included the first postcontrast acquisition; theoretic abbreviated protocol with addition of a T2-weighted sequence; and the standard full protocol) and assigned BI-RADS categories. Categories 3-5 were considered to represent positive examinations. Interreader agreement was assessed, and diagnostic performance was compared by use of pooled reader data. RESULTS. Interreader agreement on BI-RADS category, expressed as kappa values, was 0.55 for the standard, 0.45 for the abbreviated, and 0.57 for the abbreviated plus T2-weighted protocols. Pooled sensitivity was 94% for the standard, 92% for the abbreviated, and 90% for the abbreviated plus T2-weighted protocols (all p > .001). Pooled specificity was 80% for the standard, 71% for the abbreviated, and 83% for the abbreviated plus T2-weighted protocols (p < .001 for abbreviated plus T2-weighted compared with both standard and abbreviated). Pooled PPV was 19% for the standard, 14% for the abbreviated, and 20% for the abbreviated plus T2-weighted protocols (p < .001 for abbreviated compared with both standard and abbreviated). Pooled NPV was 100% for the standard, 99% for the abbreviated, and 99% for the abbreviated plus T2-weighted (all p > .001) protocols. Pooled accuracy was 80% for the standard, 73% for the abbreviated, and 83% for the abbreviated plus T2-weighted protocols (p < .001 for abbreviated compared with both standard and abbreviated plus T2-weighted). CONCLUSION. The abbreviated protocol without T2-weighted imaging had suboptimal performance. However, addition of the T2-weighted sequence yielded comparable sensitivity and accuracy and a small increase in specificity compared with the full protocol. CLINICAL IMPACT. The findings support implementation of abbreviated MRI with T2-weighted imaging for breast cancer screening of patients with BRCA mutations.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Naranjo, Sogani, Saccarelli, et al. MRI Screening of BRCA Mutation Carriers: Comparison of Standard Protocol and Abbreviated Protocols With and Without T2-Weighted Images. AJR Am J Roentgenol. 2021. PMID: 34935399. doi:10.2214/AJR.21.27022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。